Giulio Donati - Concepedia

Author

Giulio Donati

University of Bologna ORCID

Also Known As

Donati G, Donati, Giulio <1979>, G Donati, G. Donati, Giulio Donati

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Bologna European Institute of Oncology Istituti di Ricovero e Cura a Carattere Scientifico Vita-Salute San Raffaele University University of Milan

About

Giulio Donati is an author at University of Bologna specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	312
2	Cell Biology	3	3	216
3	Natural Sciences	1	1	95
4	Immunology	1	1	26
5	Molecular Biology	1	1	95

Giulio Donati

Publications

947

Citations

H-Index

Page 1

	Year	Citations
5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint Giulio Donati, Suresh Peddigari, Carol A. Mercer, Cell Reports	2013	254
Ribosome Biogenesis and Control of Cell Proliferation: p53 Is Not Alone Giulio Donati, Lorenzo Montanaro, Massimo Derenzini Cancer Research	2012	174
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy Davide Treré, Elisa Brighenti, Giulio Donati, Annals of Oncology Breast OncologyMedicineAdjuvant ChemotherapyPathologyHigh Prevalence	2009	96
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation Giulio Donati, Elisa Brighenti, Manuela Vici, Journal of Cell Science Molecular BiologyTumour Suppressor P53Tumor BiologyCell RegulationCell Signaling	2011	95
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells Giulio Donati, Serena Bertoni, Elisa Brighenti, Oncogene Tumor BiologyMammalian CellsMedicineTumour Suppressor P53Ribosomal Protein Synthesis	2011	95
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of <i>MYC</i> / <i>BCL2</i> double-hit B cell lymphoma Micol Ravà, Aleco D’Andrea, Paola Nicoli, Science Translational Medicine	2018	57
Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure Massimo Derenzini, Giulio Donati, Giuliano Mazzini, Clinical Cancer Research	2008	51
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein‐ and p53‐deficient and proficient human osteosarcoma cell lines Lorenzo Montanaro, Giuliano Mazzini, Stefania Barbieri, Cell Proliferation	2007	49
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma Giulio Donati, Micol Ravà, M. Filipuzzi, Molecular Oncology Bcl2 FamilyImmunologyPathologyCell DeathTumor Biology	2021	26
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in <scp>MYC</scp> ‐driven lymphoma Giulio Donati, Paola Nicoli, Alessandro Verrecchia, EMBO Molecular Medicine	2023	20

Page 1